Kevin Bitterman
Polaris Partners Partner
investment range
sweet spot
Kevin Bitterman's Past Investments (27)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Neuronetics | Series G | $15M | Jun 2017 | |
| Visterra | Series C | $23.1M | Jun 2016 | |
| Kala Pharmaceuticals | Series C | $68M | Apr 2016 | |
| Pulmatrix | Post-IPO Equity | $10M | Jun 2015 | |
| Arsenal Medical | Venture Round | $16M (Lead) | Jun 2015 | |
| Neuronetics | Series F | $34.3M | Apr 2015 | |
| Visterra | Series B | $30M | Oct 2014 | |
| Kala Pharmaceuticals | Series B | $22.5M | Apr 2014 | |
| Visterra | Series A | $8.1M | Dec 2013 | |
| Kala Pharmaceuticals | Series A | $11.5M | Feb 2013 |
Kevin Bitterman's Media
No media found for Kevin Bitterman.